Spray Drying of Tuberculosis vaccine

Application Note Mini Spray Dryer B-290 Tuberculosis vaccine
Spray Drying of Tuberculosis vaccine

Spray drying has been investigated as a method for producing a stable and effective tuberculosis vaccine. The tuberculosis vaccine, also known as Bacille Calmette-Guérin (BCG), is a live attenuated vaccine that is currently the only vaccine available for preventing tuberculosis. However, BCG has several limitations, including its variability in efficacy and stability.

The spray drying process involves atomizing a BCG vaccine solution into a spray of fine droplets, which are dried by hot air to produce a dry powder. The resulting powder is stable at room temperature and can be stored for extended periods without losing its efficacy.

Spray drying of tuberculosis vaccine offers several advantages, including improved stability, enhanced product uniformity, and reduced manufacturing costs. The process parameters can be optimized to control the particle size, morphology, and chemical composition of the resulting powder, which can be tailored to meet specific product requirements.

Overall, spray drying is a promising method for producing a stable and effective tuberculosis vaccine that can be used in various global health initiatives.

Please find starting paramters and some Results in this Application Note.

ダウンロード登録

いただいた個人情報は、お問い合わせへの対応や今後のビュッヒからのご案内(アプリケーションノート、ガイドブック、ウェビナーやセミナーのご案内など)についてのみ使用させていただきます。弊社の個人情報に関する取り扱いについては当社のプライバシーポリシーをご確認ください。

同様のアプリケーション